![]() |
Protein Pages Controlling and Supplying the Visual Cascade |
|
Controlling and Supplying the Visual Cascade requires control of light perception, as well as recovery of activated components involved in phototransduction. The pages shown on the right summarise the interactions and dependencies of different proteins involved in human phototransduction. To ease the access we have prepared pages providing information on the following topics: |
|
|
This page introduces you to the regulatory proteins and biochemistry of the visual cascade. If you click on a protein on the right, you will receive a description of the chosen step and further pages providing information on that protein can be accessed. |
Arrestin
Protein Kinase C Recoverin Rhodopsin Kinase Protein Phosphatase 2a Guanylate Cyclase Phosducin |
|
Click on image to enlarge
For a high quality copy of the schematics you may inquire at the pagemaster’s office. |
| Controlling the Trigger |
As we heard before metarhodopsin II (META II) formation activates transducin. During bright light illumination META II is phosphorylated by rhodopsin kinase (RHOK) at serine residues 338 and 342 in a ratio of 40:60 respectively (7) During dim light illumination and in the dark META II is phosphorylated by protein kinase C (PRKC) at the C-terminus. Phosphorylation of META II decreases its affinity to GNAT and increases its affinity to Arrestin (SAG). SAG binding prevents interactions of META II and GNAT completely. Inactivated Photopigment exchanges all-trans retinaldehyde with 11-cis retinaldehyde (see further page), detaches SAG and is dephosphorylated by protein phosphatase 2A (PP2A). Recovered photopigment starts phototransduction again with the uptake of a photon (32), (36), (19).
RHOK is a soluble Ser/ Thr kinase of the retina and pineal gland. In the retina RHOK is found in rods but not in cones. It could be shown that RHOK is attached to the disc membrane (when binding to RHO ) as well as soluble in the cytoplasm (when autophosphorylated). Its N-terminus binds to the third cytoplasmic loop of RHO and phosphorylates it independent of Ca 2+ primarily at Ser residues 343 and 338. RHOK shows autophosphorylation at Thr 489 and Ser488 and is farnesylated at Cys558. Additionally carboxymethylation could be shown. Farnesylation supports membrane attachment and Mg 2+ is a co-factor for full enzymatic activity. Therefore, both are necessary for complete activity on RHO . Autophosphorylation of RHOK reduces phosphorylation of RHO by keeping the RHOK molecule in solution. RHOK activity is controlled by binding to recoverin (RCV1). (4), (13), (14)(20), (28), (29), (31)
RCV1
is a Ca
2+
controlled protein with EF-hand Ca
2+
-binding motifs and homology to visinin. At high Ca
2+
concentrations
RCV1
is completely loaded with Ca
2+.
Ca
2+
loaded
RCV1
binds to
RHOK .
and blocks its activity.
RCV1
is further myristoylated. Myristoylation is necessary for its membrane attachment and induces a cooperative Ca
2+ dependence of
RHOK
inhibition. Lowered Ca
2+
concentrations cause membrane dissociation of
RCV1
, thus releasing the inhibition of
RHOK
activity. Raised concentrations of
RCV1
slowed therefore recovery from photoexcitation by reducing
RHO
phosphorylation.
RCV1
immunoreactivity could be shown throughout the whole photoreceptor layer of the retina with restrictions to the rods.
Knock-out mice without recoverin gene expression have been established. The missing
RCV1
led to a decrease in
RHOK
activity followed by prolonged PDE activation and impaired adaptation. But ERGs appeared normal.
(4),
(3),
(5),
(8),
(16),
(21),
(25)
Binding of
SAG
to
RHO
enhances
RHO
regeneration by blocking
RHO
preferential interactions with
GNAT
and thus providing the possibility to exchange the photobleached chromophore.
It associates to both phosphorylated and unphosphorylated META II. Phosphorylation by
protein kinase C (PRKC)
increases the affinity to
RHO .
Thus phosphorylation at high Ca2+ concentration in the dark increases
SAG
activity to enhance
RHO
regeneration even at dim light.
ATP and
Ca2+
are components to further enhance its activity.
SAG
dephosphorylation is established by calcineurin.
During light phase
SAG
localises mostly in outer segments, while during dark phase they can be found mostly in inner segments, nuclei and synaptic termini
SAG
knock-out mice have been shown to be affected only in the homozygous state. These knock-outs show very slow recovery of rod responses but not cone responses.
(2),
(9),
(10),
(12),
(24),
(27)
(34),
(36)
Protein phosphatase 2A (PP2A) is a heterotrimeric protein made of two catalytic and regulatory subunit. It specifically dephosphorylates Ser and Thr residues. A substrates for PP2A are photopigments and Phosducin . photopigments are dephosphorylated to enter the regeneration cycles. Dephosphorylated Phosducin blocks GNB-GNG from rejoining with GNAT to be reactivated. (15), (19), (30)
PRKC
belongs to a family of protein kinases with several isoforms phosphorylating
Ser
and
Thr
residues.
PRKC
isoforms are expressed in several different tissues. While isoform alpha is present as a peripheral membrane protein in
ROS
and
IPL
PRKCB
isoforms are reported to be present in the human
RPE.
PRKC
shows autophosphorylation. It is activated by phosphatidylinositol and phosphatidylserine together with
Ca2+
and a possible influence of the lipid bilayer of membranes. The affinity to these activators is increased by diacylglycerol. Isoforms
PRKCD, PRKCE, and PRKZ
show no dependence to
Ca2+.
PRKC phosphorylates
Ser
and
Thr
residues in a set of proteins that are carriers of major functions in phototransduction. The organic phosphate for this activity is taken from
ATP
and delivered to targets like
SAG ,
and the
photopigments
to regulate the trigger, and
CNCG1
to control the nerve impulse generation.
PRKC
phosphorylates
PDEG
for control of the amplification cascade.
Photopigment
phosphorylation by
PRKC
takes place at dim light and darkness and is increased by phorbol myristate.
The activity is independent of the activation state of the photoreceptor. Even opsin is phosphorylated by
PRKC.
The phosphorylation site on
rhodopsin
is not equal to that of
RHOK.
PRKC
may inhibit
RHOK
activity on the
photopigment..
Solubilised PDEG
is phosphorylated at Thr35 which decreases the binding of
GNAT
and increases the ability to inhibit
PDEA-PDEB.
PRKC
phosphorylates
CNCG1
to control the channel together with protein kinase A (PKA) and is therefore the major protein that influences the control of phototransduction
.
PKA is not abundant to retinal and subretinal tissues. Thus PKA can not be considered as candidate for a retina specific phenotype while
PRKCG
has been reported to be envolved in
RP11.
(1),
(6),
(11),
(23),
(26),
(33),
(34),
(35)
|
Click on image to enlarge
For a high quality copy of the schematics you may inquire at the pagemaster’s office. |
| Controlling the Amplification Step |
Phosducin (33-kDa protein, PDC)
An additional protein that regulates the activity of phototransduction is
PDC
, a cytoplasmic protein abundant in the retina (rods and cones) and pineal gland that binds tightly to
GNB-GNG
dimers. A prerequisite of
GNB-GNG
-binding is the atachment of a farnesyl group which mediates membrane association to get into contact with
GNB-GNG.
This way it inhibits
GTP
and
cGMP
hydrolysis by
GNAT
because rebinding of
GNAT
to
GNB-GNG
dimers, and
GTP
/
cGMP
exchange for reactivation of
GNAT
is blocked. Deactivated
GNAT
cannot bind to
PDEG2
and activation of
PDEA-PDEB
is blocked, too. Thus
PDC
is a negative regulator in phototransduction.
PDC
itself is negatively regulated by phosphorylation. PKA phosphorylates it at Ser73, while
protein phosphatase 2A
has a dephosphorylating function on
PDC
. Phosphorylation is high in the dark when there is less turnover in the visual cascade.
Phospholipase 2A
is another target of
PDC
activity. Therefore,
PDC
reacts on
PRKC
because
phospholipase 2A
produces phosphatidyl fatty acids necessary for
PRKC
stimulation.
(15),
(17),
(18),
(22)
References
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Goto Top
Return to Retina International‘s
Scientific Newsletter
Return to
Mutation Database Page
Return to pagehead
Contact the editor
Return to
Retina Scientific Newsletter
This site is maintained and edited by
Dr. rer. medic. Markus Preising, Dipl.Biol.
Molecular Genetics Laboratory
Department of Paediatric Ophthalmology, Strabismology and Ophthalmogenetics
University of Regensburg
Head: Prof. Dr. med. Birgit Lorenz